Aesthet Surg J. 2024 Jan 16;44(2):NP177-NP183. doi: 10.1093/asj/sjad304.
The World Health Organization (WHO) estimates that over 650 million adults are obese worldwide. Recently, antidiabetic medications have rapidly become popular as weight loss medications. With the rising prevalence of obesity and the increasing demand for aesthetic procedures, it is anticipated that a growing number of patients presenting for consultation will be prescribed these medications. Therefore, it is critical for practicing plastic surgeons to understand their potential synergistic effects and safety considerations. This manuscript explores the potential benefits and considerations of antidiabetic medications in plastic surgery patients for weight loss therapy. The authors discuss the mechanisms of action, clinical efficacy, potential side effects, and relevant considerations for incorporating these medications into plastic surgery practices and medical spas.
世界卫生组织(WHO)估计,全球有超过 6.5 亿成年人肥胖。最近,抗糖尿病药物迅速成为热门的减肥药物。随着肥胖症的患病率上升和对美容手术的需求增加,预计越来越多的就诊患者将被开这些药物。因此,对于执业整形医生来说,了解它们的潜在协同作用和安全注意事项至关重要。本文探讨了抗糖尿病药物在整形手术患者减肥治疗中的潜在益处和注意事项。作者讨论了这些药物的作用机制、临床疗效、潜在副作用,以及将这些药物纳入整形手术实践和医疗美容场所的相关考虑因素。